annual CAPEX:
$485.40M+$227.00M(+87.85%)Summary
- As of today (September 7, 2025), VRTX annual capital expenditures is $485.40 million, with the most recent change of +$227.00 million (+87.85%) on December 31, 2024.
- During the last 3 years, VRTX annual CAPEX has risen by +$250.40 million (+106.55%).
- VRTX annual CAPEX is now at all-time high.
Performance
VRTX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$145.70M+$105.00M(+257.99%)Summary
- As of today (September 7, 2025), VRTX quarterly capital expenditures is $145.70 million, with the most recent change of +$105.00 million (+257.99%) on June 30, 2025.
- Over the past year, VRTX quarterly CAPEX has increased by +$69.00 million (+89.96%).
- VRTX quarterly CAPEX is now -41.34% below its all-time high of $248.40 million, reached on March 31, 2024.
Performance
VRTX quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$346.70M+$69.00M(+24.85%)Summary
- As of today (September 7, 2025), VRTX TTM capital expenditures is $346.70 million, with the most recent change of +$69.00 million (+24.85%) on June 30, 2025.
- Over the past year, VRTX TTM CAPEX has dropped by -$135.10 million (-28.04%).
- VRTX TTM CAPEX is now -31.87% below its all-time high of $508.90 million, reached on September 30, 2024.
Performance
VRTX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
VRTX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +87.8% | +90.0% | -28.0% |
| 3 y3 years | +106.5% | +173.4% | +50.0% |
| 5 y5 years | +543.3% | +715.6% | +342.4% |
VRTX CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +137.1% | -41.3% | +333.6% | -31.9% | +97.1% |
| 5 y | 5-year | at high | +543.3% | -41.3% | +715.6% | -31.9% | +342.4% |
| alltime | all time | at high | >+9999.0% | -41.3% | >+9999.0% | -31.9% | >+9999.0% |
VRTX CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $145.70M(+258.0%) | $346.70M(+24.8%) |
| Mar 2025 | - | $40.70M(-56.0%) | $277.70M(-42.8%) |
| Dec 2024 | $485.40M(+87.8%) | $92.60M(+36.8%) | $485.40M(-4.6%) |
| Sep 2024 | - | $67.70M(-11.7%) | $508.90M(+5.6%) |
| Jun 2024 | - | $76.70M(-69.1%) | $481.80M(+3.7%) |
| Mar 2024 | - | $248.40M(+114.0%) | $464.70M(+79.8%) |
| Dec 2023 | $258.40M(+26.2%) | $116.10M(+186.0%) | $258.40M(+46.9%) |
| Sep 2023 | - | $40.60M(-31.9%) | $175.90M(-7.2%) |
| Jun 2023 | - | $59.60M(+41.6%) | $189.50M(+3.4%) |
| Mar 2023 | - | $42.10M(+25.3%) | $183.20M(-10.5%) |
| Dec 2022 | $204.70M(-12.9%) | $33.60M(-38.0%) | $204.70M(-12.1%) |
| Sep 2022 | - | $54.20M(+1.7%) | $232.81M(+0.7%) |
| Jun 2022 | - | $53.30M(-16.2%) | $231.14M(+1.5%) |
| Mar 2022 | - | $63.60M(+3.1%) | $227.67M(-3.1%) |
| Dec 2021 | $235.00M(-9.5%) | $61.72M(+17.5%) | $235.00M(+6.3%) |
| Sep 2021 | - | $52.52M(+5.4%) | $220.97M(-35.6%) |
| Jun 2021 | - | $49.84M(-29.7%) | $343.25M(+10.3%) |
| Mar 2021 | - | $70.93M(+48.7%) | $311.27M(+19.8%) |
| Dec 2020 | $259.80M(+244.3%) | $47.69M(-72.7%) | $259.80M(+13.5%) |
| Sep 2020 | - | $174.79M(+878.5%) | $228.87M(+192.1%) |
| Jun 2020 | - | $17.86M(-8.2%) | $78.37M(+2.0%) |
| Mar 2020 | - | $19.45M(+16.0%) | $76.86M(+1.9%) |
| Dec 2019 | $75.45M(-21.0%) | $16.76M(-31.0%) | $75.45M(+1.4%) |
| Sep 2019 | - | $24.29M(+48.5%) | $74.41M(+4.8%) |
| Jun 2019 | - | $16.36M(-9.3%) | $71.03M(-15.7%) |
| Mar 2019 | - | $18.04M(+14.8%) | $84.29M(-11.8%) |
| Dec 2018 | $95.52M(-63.2%) | $15.72M(-24.8%) | $95.52M(-22.0%) |
| Sep 2018 | - | $20.91M(-29.4%) | $122.41M(-57.8%) |
| Jun 2018 | - | $29.61M(+1.1%) | $289.83M(+4.4%) |
| Mar 2018 | - | $29.28M(-31.3%) | $277.54M(+7.0%) |
| Dec 2017 | $259.42M(+358.6%) | $42.60M(-77.4%) | $259.42M(+12.1%) |
| Sep 2017 | - | $188.34M(+987.5%) | $231.52M(+306.2%) |
| Jun 2017 | - | $17.32M(+55.2%) | $57.00M(+2.2%) |
| Mar 2017 | - | $11.16M(-24.1%) | $55.76M(-1.4%) |
| Dec 2016 | $56.57M(+24.9%) | $14.71M(+6.4%) | $56.57M(+5.9%) |
| Sep 2016 | - | $13.81M(-14.1%) | $53.41M(+8.2%) |
| Jun 2016 | - | $16.08M(+34.3%) | $49.38M(+5.7%) |
| Mar 2016 | - | $11.97M(+3.7%) | $46.72M(+3.1%) |
| Dec 2015 | $45.30M(-11.9%) | $11.54M(+18.1%) | $45.30M(-6.9%) |
| Sep 2015 | - | $9.78M(-27.1%) | $48.68M(+1.0%) |
| Jun 2015 | - | $13.42M(+27.1%) | $48.20M(+3.7%) |
| Mar 2015 | - | $10.56M(-29.2%) | $46.48M(-9.7%) |
| Dec 2014 | $51.45M(+0.1%) | $14.92M(+60.5%) | $51.45M(+0.9%) |
| Sep 2014 | - | $9.30M(-20.5%) | $51.00M(-15.3%) |
| Jun 2014 | - | $11.70M(-24.6%) | $60.21M(+19.7%) |
| Mar 2014 | - | $15.53M(+7.3%) | $50.31M(-2.1%) |
| Dec 2013 | $51.39M(-28.6%) | $14.47M(-21.8%) | $51.39M(-20.7%) |
| Sep 2013 | - | $18.51M(+928.0%) | $64.80M(-5.0%) |
| Jun 2013 | - | $1.80M(-89.2%) | $68.19M(-17.0%) |
| Mar 2013 | - | $16.61M(-40.4%) | $82.20M(+14.2%) |
| Dec 2012 | $71.97M(+106.9%) | $27.88M(+27.2%) | $71.97M(+35.6%) |
| Sep 2012 | - | $21.91M(+38.6%) | $53.06M(+28.4%) |
| Jun 2012 | - | $15.81M(+148.2%) | $41.33M(+15.6%) |
| Mar 2012 | - | $6.37M(-29.0%) | $35.76M(+2.8%) |
| Dec 2011 | $34.78M(-10.8%) | $8.97M(-11.9%) | $34.78M(-13.8%) |
| Sep 2011 | - | $10.18M(-0.6%) | $40.33M(-1.5%) |
| Jun 2011 | - | $10.24M(+89.8%) | $40.94M(+0.1%) |
| Mar 2011 | - | $5.39M(-62.9%) | $40.91M(+4.9%) |
| Dec 2010 | $39.01M(+66.0%) | $14.52M(+34.6%) | $39.01M(+21.7%) |
| Sep 2010 | - | $10.79M(+5.6%) | $32.07M(+23.2%) |
| Jun 2010 | - | $10.21M(+192.6%) | $26.03M(+27.6%) |
| Mar 2010 | - | $3.49M(-53.9%) | $20.41M(-13.1%) |
| Dec 2009 | $23.50M(-28.5%) | $7.58M(+59.4%) | $23.50M(+2.8%) |
| Sep 2009 | - | $4.75M(+3.6%) | $22.86M(-18.4%) |
| Jun 2009 | - | $4.59M(-30.3%) | $28.03M(-16.5%) |
| Mar 2009 | - | $6.58M(-5.3%) | $33.59M(+2.2%) |
| Dec 2008 | $32.88M | $6.95M(-30.0%) | $32.88M(+5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2008 | - | $9.92M(-2.2%) | $31.13M(+6.8%) |
| Jun 2008 | - | $10.14M(+73.0%) | $29.14M(-9.4%) |
| Mar 2008 | - | $5.86M(+12.8%) | $32.15M(-0.8%) |
| Dec 2007 | $32.41M(-0.0%) | $5.20M(-34.4%) | $32.41M(-5.8%) |
| Sep 2007 | - | $7.93M(-39.7%) | $34.40M(+2.8%) |
| Jun 2007 | - | $13.15M(+114.5%) | $33.47M(+7.6%) |
| Mar 2007 | - | $6.13M(-14.7%) | $31.10M(-4.1%) |
| Dec 2006 | $32.42M(+91.1%) | $7.19M(+2.7%) | $32.42M(+6.7%) |
| Sep 2006 | - | $7.00M(-35.1%) | $30.37M(+9.2%) |
| Jun 2006 | - | $10.78M(+44.6%) | $27.81M(+31.3%) |
| Mar 2006 | - | $7.45M(+44.9%) | $21.17M(+24.8%) |
| Dec 2005 | $16.96M(+34.3%) | $5.14M(+16.0%) | $16.96M(+8.6%) |
| Sep 2005 | - | $4.43M(+7.0%) | $15.62M(+20.0%) |
| Jun 2005 | - | $4.14M(+27.9%) | $13.02M(+1.2%) |
| Mar 2005 | - | $3.24M(-14.9%) | $12.86M(+2.9%) |
| Dec 2004 | $12.63M(-27.2%) | $3.80M(+107.8%) | $12.49M(-0.4%) |
| Sep 2004 | - | $1.83M(-54.0%) | $12.54M(+34.4%) |
| Jun 2004 | - | $3.98M(+38.5%) | $9.33M(-29.8%) |
| Mar 2004 | - | $2.88M(-25.3%) | $13.29M(-23.4%) |
| Dec 2003 | $17.35M(-57.9%) | $3.85M(-378.8%) | $17.35M(-27.9%) |
| Sep 2003 | - | -$1.38M(-117.4%) | $24.06M(-36.4%) |
| Jun 2003 | - | $7.94M(+14.5%) | $37.84M(-1.3%) |
| Mar 2003 | - | $6.94M(-34.3%) | $38.35M(-7.0%) |
| Dec 2002 | $41.22M(-23.5%) | $10.56M(-14.8%) | $41.22M(-2.8%) |
| Sep 2002 | - | $12.40M(+46.8%) | $42.38M(-18.4%) |
| Jun 2002 | - | $8.45M(-13.9%) | $51.95M(-3.2%) |
| Mar 2002 | - | $9.81M(-16.3%) | $53.66M(-0.4%) |
| Dec 2001 | $53.90M(+343.8%) | $11.73M(-46.6%) | $53.90M(+12.3%) |
| Sep 2001 | - | $21.97M(+116.3%) | $47.98M(+73.3%) |
| Jun 2001 | - | $10.16M(+1.1%) | $27.68M(+43.4%) |
| Mar 2001 | - | $10.05M(+72.9%) | $19.30M(+62.0%) |
| Dec 2000 | $12.15M(-25.1%) | $5.81M(+248.0%) | $11.91M(+34.7%) |
| Sep 2000 | - | $1.67M(-6.1%) | $8.84M(-31.0%) |
| Jun 2000 | - | $1.78M(-33.0%) | $12.81M(-21.9%) |
| Mar 2000 | - | $2.65M(-3.1%) | $16.40M(+1.2%) |
| Dec 1999 | $16.21M(+105.2%) | $2.74M(-51.4%) | $16.21M(+3.6%) |
| Sep 1999 | - | $5.64M(+5.0%) | $15.64M(+39.2%) |
| Jun 1999 | - | $5.37M(+118.3%) | $11.23M(+38.0%) |
| Mar 1999 | - | $2.46M(+13.3%) | $8.14M(+3.1%) |
| Dec 1998 | $7.90M(+27.0%) | $2.17M(+76.1%) | $7.90M(+3.6%) |
| Sep 1998 | - | $1.23M(-45.9%) | $7.63M(+1.8%) |
| Jun 1998 | - | $2.28M(+2.8%) | $7.50M(+26.7%) |
| Mar 1998 | - | $2.22M(+16.7%) | $5.92M(-1.4%) |
| Dec 1997 | $6.22M(+56.2%) | $1.90M(+72.7%) | $6.00M(-6.3%) |
| Sep 1997 | - | $1.10M(+57.1%) | $6.40M(+8.5%) |
| Jun 1997 | - | $700.00K(-69.6%) | $5.90M(+3.5%) |
| Mar 1997 | - | $2.30M(0.0%) | $5.70M(+42.5%) |
| Dec 1996 | $3.98M(+26.7%) | $2.30M(+283.3%) | $4.00M(-25.9%) |
| Sep 1996 | - | $600.00K(+20.0%) | $5.40M(-1.8%) |
| Jun 1996 | - | $500.00K(-16.7%) | $5.50M(0.0%) |
| Mar 1996 | - | $600.00K(-83.8%) | $5.50M(+1.9%) |
| Dec 1995 | $3.14M(+20.9%) | $3.70M(+428.6%) | $5.40M(+157.1%) |
| Sep 1995 | - | $700.00K(+40.0%) | $2.10M(+23.5%) |
| Jun 1995 | - | $500.00K(0.0%) | $1.70M(+54.5%) |
| Mar 1995 | - | $500.00K(+25.0%) | $1.10M(-42.1%) |
| Dec 1994 | $2.60M(+40.8%) | $400.00K(+33.3%) | $1.90M(+5.6%) |
| Sep 1994 | - | $300.00K(-400.0%) | $1.80M(-5.3%) |
| Jun 1994 | - | -$100.00K(-107.7%) | $1.90M(0.0%) |
| Mar 1994 | - | $1.30M(+333.3%) | $1.90M(+5.6%) |
| Dec 1993 | $1.85M(+48.8%) | $300.00K(-25.0%) | $1.80M(-33.3%) |
| Sep 1993 | - | $400.00K(-500.0%) | $2.70M(+42.1%) |
| Jun 1993 | - | -$100.00K(-108.3%) | $1.90M(+5.6%) |
| Mar 1993 | - | $1.20M(0.0%) | $1.80M(+20.0%) |
| Dec 1992 | $1.24M(-6.4%) | $1.20M(-400.0%) | $1.50M(+400.0%) |
| Sep 1992 | - | -$400.00K(+100.0%) | $300.00K(-57.1%) |
| Jun 1992 | - | -$200.00K(-122.2%) | $700.00K(-22.2%) |
| Mar 1992 | - | $900.00K | $900.00K |
| Dec 1991 | $1.33M | - | - |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual capital expenditures?
- What is the all time high annual CAPEX for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual CAPEX year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly CAPEX year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM capital expenditures?
- What is the all time high TTM CAPEX for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM CAPEX year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual capital expenditures?
The current annual CAPEX of VRTX is $485.40M
What is the all time high annual CAPEX for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual capital expenditures is $485.40M
What is Vertex Pharmaceuticals Incorporated annual CAPEX year-on-year change?
Over the past year, VRTX annual capital expenditures has changed by +$227.00M (+87.85%)
What is Vertex Pharmaceuticals Incorporated quarterly capital expenditures?
The current quarterly CAPEX of VRTX is $145.70M
What is the all time high quarterly CAPEX for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly capital expenditures is $248.40M
What is Vertex Pharmaceuticals Incorporated quarterly CAPEX year-on-year change?
Over the past year, VRTX quarterly capital expenditures has changed by +$69.00M (+89.96%)
What is Vertex Pharmaceuticals Incorporated TTM capital expenditures?
The current TTM CAPEX of VRTX is $346.70M
What is the all time high TTM CAPEX for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM capital expenditures is $508.90M
What is Vertex Pharmaceuticals Incorporated TTM CAPEX year-on-year change?
Over the past year, VRTX TTM capital expenditures has changed by -$135.10M (-28.04%)